Ir para o conteúdo principal

United States Últimas notícias

Todas as matérias desta categoria, das mais recentes às mais antigas.

Grafa
Health

Sagimet Biosciences advances MASH and acne programs following key regulatory milestones

Sagimet Biosciences (NASDAQ:SGMT), a clinical-stage biopharmaceutical company developing novel fatty acid synthase (FASN) inhibitors, reported its fourth-quarter and full-year 2025 financial results on Wednesday.

Leia mais: Sagimet Biosciences advances MASH and acne programs following key regulatory milestones
Grafa
Health

60 Degrees Pharmaceuticals reports 100% cure rate in relapsing babesiosis trial

60 Degrees Pharmaceuticals (NASDAQ:SXTP), a specialist in medicines for vector-borne diseases, announced Wednesday that all three patients enrolled in its expanded-use clinical trial for relapsing babesiosis were successfully cured.

Leia mais: 60 Degrees Pharmaceuticals reports 100% cure rate in relapsing babesiosis trial